146 related articles for article (PubMed ID: 25611048)
1. Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy?
Tamamyan G; Dominkus M; Lang S; Diakos C; Mittheisz E; Horcher E; Holter W; Zoubek A; Bielack S; Kager L
Pediatr Blood Cancer; 2015 Mar; 62(3):529-30. PubMed ID: 25611048
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
3. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
4. Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience.
Brandal P; Bjerkehagen B; Bruland OS; Skjeldal S; Bogsrud TV; Hall KS
Acta Oncol; 2009; 48(8):1165-72. PubMed ID: 19863225
[TBL] [Abstract][Full Text] [Related]
5. Review of management issues in relapsed osteosarcoma.
Vijayamurugan N; Bakhshi S
Expert Rev Anticancer Ther; 2014 Feb; 14(2):151-61. PubMed ID: 24308680
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
[TBL] [Abstract][Full Text] [Related]
8. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.
Chou AJ; Merola PR; Wexler LH; Gorlick RG; Vyas YM; Healey JH; LaQuaglia MP; Huvos AG; Meyers PA
Cancer; 2005 Nov; 104(10):2214-21. PubMed ID: 16206297
[TBL] [Abstract][Full Text] [Related]
9. The use of bone allografts for limb salvage in high-grade extremity osteosarcoma.
Gebhardt MC; Flugstad DI; Springfield DS; Mankin HJ
Clin Orthop Relat Res; 1991 Sep; (270):181-96. PubMed ID: 1884538
[TBL] [Abstract][Full Text] [Related]
10. [High grade osteosarcoma of the lower limb. Complications and results of the treatment of 20 patients].
Babin SR; Simon P; Babin-Boilletot A; Bellocq JP; Marcellin L; Dosch JC
Rev Chir Orthop Reparatrice Appar Mot; 1996; 82(1):14-21. PubMed ID: 8762984
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma: the COSS experience.
Bielack S; Jürgens H; Jundt G; Kevric M; Kühne T; Reichardt P; Zoubek A; Werner M; Winkelmann W; Kotz R
Cancer Treat Res; 2009; 152():289-308. PubMed ID: 20213397
[TBL] [Abstract][Full Text] [Related]
13. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy.
Wang TI; Wu PK; Chen CF; Chen WM; Yen CC; Hung GY; Liu CL; Chen TH
Jpn J Clin Oncol; 2011 Nov; 41(11):1244-50. PubMed ID: 21994209
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.
Sauerbrey A; Bielack S; Kempf-Bielack B; Zoubek A; Paulussen M; Zintl F
Bone Marrow Transplant; 2001 May; 27(9):933-7. PubMed ID: 11436103
[TBL] [Abstract][Full Text] [Related]
16. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
17. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
[TBL] [Abstract][Full Text] [Related]
18. What is the best clinical approach to recurrent/refractory osteosarcoma?
Meazza C; Bastoni S; Scanagatta P
Expert Rev Anticancer Ther; 2020 May; 20(5):415-428. PubMed ID: 32379504
[No Abstract] [Full Text] [Related]
19. Prognostic relevance of increased angiogenesis in osteosarcoma.
Kreuter M; Bieker R; Bielack SS; Auras T; Buerger H; Gosheger G; Jurgens H; Berdel WE; Mesters RM
Clin Cancer Res; 2004 Dec; 10(24):8531-7. PubMed ID: 15623635
[TBL] [Abstract][Full Text] [Related]
20. Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2.
Geller DS; Singh MY; Zhang W; Gill J; Roth ME; Kim MY; Xie X; Singh CK; Dorfman HD; Villanueva-Siles E; Park A; Piperdi S; Gorlick R
Clin Cancer Res; 2015 Jul; 21(13):3003-12. PubMed ID: 25472999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
